HopeStage
Back to all studies
RecruitingNCT05669534

Testing cognitive supports for HIV prevention among people on PrEP and opioid treatment

About this titleRead the official source — NCT05669534
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
New HavenSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
256
Sponsor
University of Connecticut
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05669534
Official title
Show the full official title

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Recruitment & locations

Currently recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Connecticut, a university.

Does this study involve medication?

Yes. The study involves medication, including Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies